Cargando…
Safety Assessment of a Nucleoside Analogue FNC (2’-deoxy-2’-β-fluoro-4’-azidocytidine ) in Balb/c Mice: Acute Toxicity Study
OBJECTIVES: The present study aimed to provide an insight into the acute toxicity of a novel fluorinated nucleoside analogue (FNA), FNC (Azvudine or2’-deoxy-2’-β-fluoro-4’-azidocytidine). FNC showed potent anti-viral and anti-cancer activities and approved drug for high-load HIV patients, despite, i...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
West Asia Organization for Cancer Prevention
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10505880/ https://www.ncbi.nlm.nih.gov/pubmed/37378948 http://dx.doi.org/10.31557/APJCP.2023.24.6.2157 |
_version_ | 1785106999791321088 |
---|---|
author | Kumar, Naveen Delu, Vikram Shukla, Alok Singh, Rishi Kant Ulasov, Ilya Fayzullina, Daria Kuma, Sandeep Patel, Anand Kumar Yadav, Lokesh Tiwari, Ruchi Rachana, Kumari Mohanta, Shivashish Priyadarshi Kumar, Sanjay Kaushalendra, Kaushalendra Acharya, Arbind |
author_facet | Kumar, Naveen Delu, Vikram Shukla, Alok Singh, Rishi Kant Ulasov, Ilya Fayzullina, Daria Kuma, Sandeep Patel, Anand Kumar Yadav, Lokesh Tiwari, Ruchi Rachana, Kumari Mohanta, Shivashish Priyadarshi Kumar, Sanjay Kaushalendra, Kaushalendra Acharya, Arbind |
author_sort | Kumar, Naveen |
collection | PubMed |
description | OBJECTIVES: The present study aimed to provide an insight into the acute toxicity of a novel fluorinated nucleoside analogue (FNA), FNC (Azvudine or2’-deoxy-2’-β-fluoro-4’-azidocytidine). FNC showed potent anti-viral and anti-cancer activities and approved drug for high-load HIV patients, despite, its acute toxicity study being lacking. MATERIALS AND METHODS: OECD-423 guidelines were followed during this study and the parameters were divided into four categories - behavioral parameters, physiological parameters, histopathological parameters, and supplementary tests. The behavioral parameters included feeding, body weight, belly size, organ weight and size, and mice behavior. The physiological parameters consisted of blood, liver, and kidney indicators. In histopathological parameters hematoxylin and eosin staining was performed to analyse the histological changes in the mice organs after FNC exposure. In addition, supplementary tests were conducted to assess cellular viability, DNA fragmentation and cytokine levels (IL-6 and TNF-α) in response to FNC. RESULTS: In the behavioral parameters FNC induced changes in the mice-to-mice interaction and activities. Mice’s body weight, belly size, organ weight, and size remained unchanged. Physiological parameters of blood showed that FNC increased the level of WBC, RBC, Hb, and neutrophils and decreased the % count of lymphocytes. Liver enzymes SGOT (AST), and ALP was increased. In the renal function test (RFT) cholesterol level was significantly decreased. Histopathological analysis of the liver, kidney, brain, heart, lungs, and spleen showed no sign of tissue damage at the highest FNC dose of 25 mg/kg b.wt. Supplementary tests for cell viability showed no change in viability footprint, through our recently developed dilution cum-trypan (DCT) assay, and Annexin/PI. No DNA damage or apoptosis was observed in DAPI or AO/EtBr studies. Pro-inflammatory cytokines IL-6 and TNF-α increased in a dose-dependent manner. CONCLUSION: This study concluded that FNC is safe to use though higher concentration shows slight toxicity. |
format | Online Article Text |
id | pubmed-10505880 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | West Asia Organization for Cancer Prevention |
record_format | MEDLINE/PubMed |
spelling | pubmed-105058802023-09-19 Safety Assessment of a Nucleoside Analogue FNC (2’-deoxy-2’-β-fluoro-4’-azidocytidine ) in Balb/c Mice: Acute Toxicity Study Kumar, Naveen Delu, Vikram Shukla, Alok Singh, Rishi Kant Ulasov, Ilya Fayzullina, Daria Kuma, Sandeep Patel, Anand Kumar Yadav, Lokesh Tiwari, Ruchi Rachana, Kumari Mohanta, Shivashish Priyadarshi Kumar, Sanjay Kaushalendra, Kaushalendra Acharya, Arbind Asian Pac J Cancer Prev Research Article OBJECTIVES: The present study aimed to provide an insight into the acute toxicity of a novel fluorinated nucleoside analogue (FNA), FNC (Azvudine or2’-deoxy-2’-β-fluoro-4’-azidocytidine). FNC showed potent anti-viral and anti-cancer activities and approved drug for high-load HIV patients, despite, its acute toxicity study being lacking. MATERIALS AND METHODS: OECD-423 guidelines were followed during this study and the parameters were divided into four categories - behavioral parameters, physiological parameters, histopathological parameters, and supplementary tests. The behavioral parameters included feeding, body weight, belly size, organ weight and size, and mice behavior. The physiological parameters consisted of blood, liver, and kidney indicators. In histopathological parameters hematoxylin and eosin staining was performed to analyse the histological changes in the mice organs after FNC exposure. In addition, supplementary tests were conducted to assess cellular viability, DNA fragmentation and cytokine levels (IL-6 and TNF-α) in response to FNC. RESULTS: In the behavioral parameters FNC induced changes in the mice-to-mice interaction and activities. Mice’s body weight, belly size, organ weight, and size remained unchanged. Physiological parameters of blood showed that FNC increased the level of WBC, RBC, Hb, and neutrophils and decreased the % count of lymphocytes. Liver enzymes SGOT (AST), and ALP was increased. In the renal function test (RFT) cholesterol level was significantly decreased. Histopathological analysis of the liver, kidney, brain, heart, lungs, and spleen showed no sign of tissue damage at the highest FNC dose of 25 mg/kg b.wt. Supplementary tests for cell viability showed no change in viability footprint, through our recently developed dilution cum-trypan (DCT) assay, and Annexin/PI. No DNA damage or apoptosis was observed in DAPI or AO/EtBr studies. Pro-inflammatory cytokines IL-6 and TNF-α increased in a dose-dependent manner. CONCLUSION: This study concluded that FNC is safe to use though higher concentration shows slight toxicity. West Asia Organization for Cancer Prevention 2023 /pmc/articles/PMC10505880/ /pubmed/37378948 http://dx.doi.org/10.31557/APJCP.2023.24.6.2157 Text en https://creativecommons.org/licenses/by-nc/4.0/This work is licensed under a Creative Commons Attribution-Non Commercial 4.0 International License. (https://creativecommons.org/licenses/by-nc/4.0/) |
spellingShingle | Research Article Kumar, Naveen Delu, Vikram Shukla, Alok Singh, Rishi Kant Ulasov, Ilya Fayzullina, Daria Kuma, Sandeep Patel, Anand Kumar Yadav, Lokesh Tiwari, Ruchi Rachana, Kumari Mohanta, Shivashish Priyadarshi Kumar, Sanjay Kaushalendra, Kaushalendra Acharya, Arbind Safety Assessment of a Nucleoside Analogue FNC (2’-deoxy-2’-β-fluoro-4’-azidocytidine ) in Balb/c Mice: Acute Toxicity Study |
title | Safety Assessment of a Nucleoside Analogue FNC (2’-deoxy-2’-β-fluoro-4’-azidocytidine ) in Balb/c Mice: Acute Toxicity Study |
title_full | Safety Assessment of a Nucleoside Analogue FNC (2’-deoxy-2’-β-fluoro-4’-azidocytidine ) in Balb/c Mice: Acute Toxicity Study |
title_fullStr | Safety Assessment of a Nucleoside Analogue FNC (2’-deoxy-2’-β-fluoro-4’-azidocytidine ) in Balb/c Mice: Acute Toxicity Study |
title_full_unstemmed | Safety Assessment of a Nucleoside Analogue FNC (2’-deoxy-2’-β-fluoro-4’-azidocytidine ) in Balb/c Mice: Acute Toxicity Study |
title_short | Safety Assessment of a Nucleoside Analogue FNC (2’-deoxy-2’-β-fluoro-4’-azidocytidine ) in Balb/c Mice: Acute Toxicity Study |
title_sort | safety assessment of a nucleoside analogue fnc (2’-deoxy-2’-β-fluoro-4’-azidocytidine ) in balb/c mice: acute toxicity study |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10505880/ https://www.ncbi.nlm.nih.gov/pubmed/37378948 http://dx.doi.org/10.31557/APJCP.2023.24.6.2157 |
work_keys_str_mv | AT kumarnaveen safetyassessmentofanucleosideanaloguefnc2deoxy2bfluoro4azidocytidineinbalbcmiceacutetoxicitystudy AT deluvikram safetyassessmentofanucleosideanaloguefnc2deoxy2bfluoro4azidocytidineinbalbcmiceacutetoxicitystudy AT shuklaalok safetyassessmentofanucleosideanaloguefnc2deoxy2bfluoro4azidocytidineinbalbcmiceacutetoxicitystudy AT singhrishikant safetyassessmentofanucleosideanaloguefnc2deoxy2bfluoro4azidocytidineinbalbcmiceacutetoxicitystudy AT ulasovilya safetyassessmentofanucleosideanaloguefnc2deoxy2bfluoro4azidocytidineinbalbcmiceacutetoxicitystudy AT fayzullinadaria safetyassessmentofanucleosideanaloguefnc2deoxy2bfluoro4azidocytidineinbalbcmiceacutetoxicitystudy AT kumasandeep safetyassessmentofanucleosideanaloguefnc2deoxy2bfluoro4azidocytidineinbalbcmiceacutetoxicitystudy AT patelanandkumar safetyassessmentofanucleosideanaloguefnc2deoxy2bfluoro4azidocytidineinbalbcmiceacutetoxicitystudy AT yadavlokesh safetyassessmentofanucleosideanaloguefnc2deoxy2bfluoro4azidocytidineinbalbcmiceacutetoxicitystudy AT tiwariruchi safetyassessmentofanucleosideanaloguefnc2deoxy2bfluoro4azidocytidineinbalbcmiceacutetoxicitystudy AT rachanakumari safetyassessmentofanucleosideanaloguefnc2deoxy2bfluoro4azidocytidineinbalbcmiceacutetoxicitystudy AT mohantashivashishpriyadarshi safetyassessmentofanucleosideanaloguefnc2deoxy2bfluoro4azidocytidineinbalbcmiceacutetoxicitystudy AT kumarsanjay safetyassessmentofanucleosideanaloguefnc2deoxy2bfluoro4azidocytidineinbalbcmiceacutetoxicitystudy AT kaushalendrakaushalendra safetyassessmentofanucleosideanaloguefnc2deoxy2bfluoro4azidocytidineinbalbcmiceacutetoxicitystudy AT acharyaarbind safetyassessmentofanucleosideanaloguefnc2deoxy2bfluoro4azidocytidineinbalbcmiceacutetoxicitystudy |